Jin Yong Kim
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Jin Yong Kim has a total of 246 co-authors. Here are the top co-authors by number of shared publications:
Dong Kyung Chang
27 shared publicationsJong Chul Rhee
27 shared publications- Poong-Lyul Rhee
Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine
25 shared publications Young-Ho Kim
19 shared publicationsJae J. Kim
18 shared publicationsHee Jung Son
Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
15 shared publications
Latest Publications
- 1 February 2014
- Published by Wolters Kluwer Health in Annals of Surgery
- Vol. 259 (2) , 323-328
Should Preoperative Chest CT Be Recommended to All Colon Cancer Patients?
The aim of this study was to evaluate the efficacy of preoperative chest computed tomography (CT) and the risk factors for lung metastasis in colon cancer patients without liver metastasis who had negative findings on initial chest X-ray (CXR). Preoperative staging with chest CT is recommended in colon cancer patients. However, there have been only scant data on the clinical efficacy. Three hundred nineteen consecutive colon cancer patients without liver metastasis were retrospectively reviewed and analyzed. The patients had negative findings on preoperative CXR, and they underwent surgery for colon cancer during the period of January 2008 to April 2010. Lung nodule on chest CT was found in 136 patients (42.6%). Twenty of those were definitely diagnosed with lung metastasis (6.3%) by follow-up chest CT or pathologic confirmation. There was no case of delay in surgery due to findings of lung nodule. Comparing the group with lung metastases to that without lung metastases, postoperative pathologic findings reported more advanced T and N status (P = 0.004, P < 0.001, respectively), and lymphatic invasion was more frequent (P = 0.003) in the group with lung metastasis. By multivariate analysis, CT-predicted lymph node metastases and pathologic lymph node metastases were risk factors for lung metastases. Preoperative staging chest CT is not beneficial to colon cancer patients without liver metastasis and lymph node metastasis suggested on abdominal and pelvic CT who had negative finding on initial CXR.
- 1 February 2014
- Published by Wolters Kluwer Health in Annals of Surgery
- Vol. 259 (2) , 323-328
Should Preoperative Chest CT Be Recommended to All Colon Cancer Patients?
The aim of this study was to evaluate the efficacy of preoperative chest computed tomography (CT) and the risk factors for lung metastasis in colon cancer patients without liver metastasis who had negative findings on initial chest X-ray (CXR). Preoperative staging with chest CT is recommended in colon cancer patients. However, there have been only scant data on the clinical efficacy. Three hundred nineteen consecutive colon cancer patients without liver metastasis were retrospectively reviewed and analyzed. The patients had negative findings on preoperative CXR, and they underwent surgery for colon cancer during the period of January 2008 to April 2010. Lung nodule on chest CT was found in 136 patients (42.6%). Twenty of those were definitely diagnosed with lung metastasis (6.3%) by follow-up chest CT or pathologic confirmation. There was no case of delay in surgery due to findings of lung nodule. Comparing the group with lung metastases to that without lung metastases, postoperative pathologic findings reported more advanced T and N status (P = 0.004, P < 0.001, respectively), and lymphatic invasion was more frequent (P = 0.003) in the group with lung metastasis. By multivariate analysis, CT-predicted lymph node metastases and pathologic lymph node metastases were risk factors for lung metastases. Preoperative staging chest CT is not beneficial to colon cancer patients without liver metastasis and lymph node metastasis suggested on abdominal and pelvic CT who had negative finding on initial CXR.
- Open Access
- 15 September 2013
- Published by The Editorial Office of Gut and Liver in Gut and Liver
- Vol. 7 (5) , 519-523
Association between Plasma Levels of Plasminogen Activator Inhibitor-1 and Colorectal Neoplasms
Plasminogen activator inhibitor-1 (PAI-1) is important for tumor growth, Invasion, and metastasis. In this study, we investigated the relationship between plasma levels of PAI-1 and colorectal adenomas. We reviewed the medical records of 3,136 subjects who underwent colonoscopy as a screening exam. The subjects were classified into a case group with adenomas (n=990) and a control group (n=2,146). Plasma PAI-1 levels were categorized into three groups based on tertile. The plasma levels of PAI-1 were significantly higher in adenoma cases than in controls (p=0.023). The prevalence of colorectal adenomas increased significantly with increasing levels of PAI-1 (p=0.038). In the adenoma group, advanced pathologic features, size, and number of adenomas did not differ among the three groups based on tertiles for plasma PAI-1 levels. Using multivariate analysis, we found that plasma level of PAI-1 was not associated with the risk of colorectal adenomas (p=0.675). Adjusted odds ratios for colorectal adenomas according to increasing plasma levels of PAI-1 were 0.980 (95% confidence interval [CI], 0.768 to 1.251) for the second-highest plasma level and 1.091 (95% CI, 0.898 to 1.326) for the highest level, compared with the lowest levels. These results suggest that elevated plasma PAI-1 levels are not associated with the risk of colorectal neoplasms.
- 15 September 2013
- Published by The Editorial Office of Gut and Liver in Gut and Liver
- Vol. 7 (5) , 519-523
Open AccessAssociation between Plasma Levels of Plasminogen Activator Inhibitor-1 and Colorectal Neoplasms
Plasminogen activator inhibitor-1 (PAI-1) is important for tumor growth, Invasion, and metastasis. In this study, we investigated the relationship between plasma levels of PAI-1 and colorectal adenomas. We reviewed the medical records of 3,136 subjects who underwent colonoscopy as a screening exam. The subjects were classified into a case group with adenomas (n=990) and a control group (n=2,146). Plasma PAI-1 levels were categorized into three groups based on tertile. The plasma levels of PAI-1 were significantly higher in adenoma cases than in controls (p=0.023). The prevalence of colorectal adenomas increased significantly with increasing levels of PAI-1 (p=0.038). In the adenoma group, advanced pathologic features, size, and number of adenomas did not differ among the three groups based on tertiles for plasma PAI-1 levels. Using multivariate analysis, we found that plasma level of PAI-1 was not associated with the risk of colorectal adenomas (p=0.675). Adjusted odds ratios for colorectal adenomas according to increasing plasma levels of PAI-1 were 0.980 (95% confidence interval [CI], 0.768 to 1.251) for the second-highest plasma level and 1.091 (95% CI, 0.898 to 1.326) for the highest level, compared with the lowest levels. These results suggest that elevated plasma PAI-1 levels are not associated with the risk of colorectal neoplasms.
- 1 June 2013
- Published by Elsevier in Clinics and Research in Hepatology and Gastroenterology
- Vol. 37 (3) , 275-282
Treatment outcomes according to endoscopic treatment modalities for rectal carcinoid tumors
- 1 June 2013
- Published by Elsevier in Clinics and Research in Hepatology and Gastroenterology
- Vol. 37 (3) , 275-282
Treatment outcomes according to endoscopic treatment modalities for rectal carcinoid tumors
- 1 January 2013
- Published by Wolters Kluwer Health in Diseases of the Colon & Rectum
- Vol. 56 (1) , 35-42
Risk Factors for Residual Cancer and Lymph Node Metastasis After Noncurative Endoscopic Resection of Early Colorectal Cancer
BACKGROUND: Endoscopic resection could be a curative treatment for early colorectal cancer without the possibility of lymph node metastasis. However, if the resection margin is positive, and there is a risk of lymph node metastasis, additional surgery should be performed. OBJECTIVE: The aim of this study was to investigate the characteristics of patients who underwent additional surgery to determine risk factors associated with residual tumor and lymph node metastasis. DESIGN: This study is a retrospective analysis. SETTINGS: This study was conducted at a tertiary academic hospital. PATIENTS: We evaluated 85 patients who underwent additional surgery with curative intent after endoscopic resection for early colorectal cancer at the Samsung Medical Center, Seoul, South Korea, between January 2001 and April 2010. MAIN OUTCOME MEASURES: We identified risk factors associated with residual tumor or lymph node metastasis in surgical specimens after noncurative endoscopic resection for early colorectal cancer. RESULTS: Among 85 patients who underwent additional surgery after noncurative endoscopic resection, 76 (89.4%) had submucosal invasion greater than 1000 μm. Twenty-one (24.7%) and 25 patients (29.4%) had a positive lateral or vertical resection margin, and 11 patients (12.9%) had inadequate lifting sign. After additional surgery, patients were divided into 2 groups according to the presence or absence of residual tumor and/or lymph node metastasis. There was no significant difference between the groups in positive lateral margin, but there was a significant difference in positive vertical margin (p = 0.015 with an OR of 15.02). In patients with inadequate lifting sign, the OR was 13.68 (p = 0.013). LIMITATIONS: This study was limited by its retrospective nature. CONCLUSION: There is a greater need for additional surgery in cases with positive vertical resection margin or inadequate lifting sign, because the risk of residual tumor and lymph node metastasis is higher than in other cases.
- 1 January 2013
- Published by Wolters Kluwer Health in Diseases of the Colon & Rectum
- Vol. 56 (1) , 35-42
Risk Factors for Residual Cancer and Lymph Node Metastasis After Noncurative Endoscopic Resection of Early Colorectal Cancer
BACKGROUND: Endoscopic resection could be a curative treatment for early colorectal cancer without the possibility of lymph node metastasis. However, if the resection margin is positive, and there is a risk of lymph node metastasis, additional surgery should be performed. OBJECTIVE: The aim of this study was to investigate the characteristics of patients who underwent additional surgery to determine risk factors associated with residual tumor and lymph node metastasis. DESIGN: This study is a retrospective analysis. SETTINGS: This study was conducted at a tertiary academic hospital. PATIENTS: We evaluated 85 patients who underwent additional surgery with curative intent after endoscopic resection for early colorectal cancer at the Samsung Medical Center, Seoul, South Korea, between January 2001 and April 2010. MAIN OUTCOME MEASURES: We identified risk factors associated with residual tumor or lymph node metastasis in surgical specimens after noncurative endoscopic resection for early colorectal cancer. RESULTS: Among 85 patients who underwent additional surgery after noncurative endoscopic resection, 76 (89.4%) had submucosal invasion greater than 1000 μm. Twenty-one (24.7%) and 25 patients (29.4%) had a positive lateral or vertical resection margin, and 11 patients (12.9%) had inadequate lifting sign. After additional surgery, patients were divided into 2 groups according to the presence or absence of residual tumor and/or lymph node metastasis. There was no significant difference between the groups in positive lateral margin, but there was a significant difference in positive vertical margin (p = 0.015 with an OR of 15.02). In patients with inadequate lifting sign, the OR was 13.68 (p = 0.013). LIMITATIONS: This study was limited by its retrospective nature. CONCLUSION: There is a greater need for additional surgery in cases with positive vertical resection margin or inadequate lifting sign, because the risk of residual tumor and lymph node metastasis is higher than in other cases.
- 1 August 2012
- Published by Elsevier in Clinics and Research in Hepatology and Gastroenterology
- Vol. 36 (4) , 378-383
Clinical usefulness of microsatellite instability test in Korean young patients with high-risk features associated with adenoma
- 1 August 2012
- Published by Elsevier in Clinics and Research in Hepatology and Gastroenterology
- Vol. 36 (4) , 378-383
Clinical usefulness of microsatellite instability test in Korean young patients with high-risk features associated with adenoma
- 1 April 2012
- Published by Elsevier in Gastrointestinal Endoscopy
- Vol. 75 (4) , AB326
Su1421 Treatment Outcome According to Treatment Modality in Rectal Carcinoid Less Than 10mm in Size
- 1 April 2012
- Published by Elsevier in Gastrointestinal Endoscopy
- Vol. 75 (4) , AB326
Su1421 Treatment Outcome According to Treatment Modality in Rectal Carcinoid Less Than 10mm in Size
- 22 March 2012
- Published by Springer Nature in Surgical Endoscopy
- Vol. 26 (6) , 1690-1695
Factors associated with adherence to the recommended postpolypectomy surveillance interval
- 22 March 2012
- Published by Springer Nature in Surgical Endoscopy
- Vol. 26 (6) , 1690-1695
Factors associated with adherence to the recommended postpolypectomy surveillance interval
- 1 February 2012
- Published by Elsevier in Clinics and Research in Hepatology and Gastroenterology
- Vol. 36 (1) , 78-83
Influence of non-alcoholic fatty liver disease on the prognosis in patients with colorectal cancer
- 1 February 2012
- Published by Elsevier in Clinics and Research in Hepatology and Gastroenterology
- Vol. 36 (1) , 78-83
Influence of non-alcoholic fatty liver disease on the prognosis in patients with colorectal cancer
- 12 January 2012
- Published by S. Karger AG in Acta Haematologica
- Vol. 127 (3) , 129-134
Endoscopic Findings in Mantle Cell Lymphoma with Gastrointestinal Tract Involvement
Background and Aims: Mantle cell lymphoma (MCL) of the gastrointestinal (GI) tract is a rare disease with a poor prognosis. The aim of this study was to determine clinical and endoscopic characteristics of patients with GI MCL. Methods: Clinical features of 19 patients with GI MCL were reviewed along with the endoscopic findings on 27 anatomical lesions. Results: The initial presenting symptoms were abdominal pain (n = 7, 36.8%), GI tract bleeding (n = 5, 26.3%), dyspnea (n = 2, 10.5%), indigestion (n = 1, 5.3%), diarrhea (n = 1, 5.3%), cervical lymphadenopathy (n = 1, 5.3%), tonsilar mass (n = 1, 5.3%), and no symptoms (n = 1, 5.3%). On endoscopy, in 19 patients with 27 lesions, the anatomic locations of the lesions were: stomach, n = 2 (10.5%); stomach and colon, n = 7 (36.8%); terminal ileum and colon, n = 1 (5.3%); colon, n = 9 (47.4%). There was 1 fungating case (3.7%), 4 ulcerative cases (14.8%), 9 infiltrative cases (33.3%), and 13 polypoid cases (48.1%). Conclusions: The endoscopic findings in GI MCL are variable, with common presenting manifestations of abdominal pain and GI bleeding.
- 12 January 2012
- Published by S. Karger AG in Acta Haematologica
- Vol. 127 (3) , 129-134
Endoscopic Findings in Mantle Cell Lymphoma with Gastrointestinal Tract Involvement
Background and Aims: Mantle cell lymphoma (MCL) of the gastrointestinal (GI) tract is a rare disease with a poor prognosis. The aim of this study was to determine clinical and endoscopic characteristics of patients with GI MCL. Methods: Clinical features of 19 patients with GI MCL were reviewed along with the endoscopic findings on 27 anatomical lesions. Results: The initial presenting symptoms were abdominal pain (n = 7, 36.8%), GI tract bleeding (n = 5, 26.3%), dyspnea (n = 2, 10.5%), indigestion (n = 1, 5.3%), diarrhea (n = 1, 5.3%), cervical lymphadenopathy (n = 1, 5.3%), tonsilar mass (n = 1, 5.3%), and no symptoms (n = 1, 5.3%). On endoscopy, in 19 patients with 27 lesions, the anatomic locations of the lesions were: stomach, n = 2 (10.5%); stomach and colon, n = 7 (36.8%); terminal ileum and colon, n = 1 (5.3%); colon, n = 9 (47.4%). There was 1 fungating case (3.7%), 4 ulcerative cases (14.8%), 9 infiltrative cases (33.3%), and 13 polypoid cases (48.1%). Conclusions: The endoscopic findings in GI MCL are variable, with common presenting manifestations of abdominal pain and GI bleeding.